Philosys Healthcare Signs Supply Contract for COVID-19 Diagnostic Rapid Kits in Europe and Other Regions
[Asia Economy Reporter Oh Ju-yeon] Philosis Healthcare announced on the 13th that it has signed a supply contract for COVID-19 diagnostic rapid kits worth 3.3 billion KRW in Europe and the Middle East. This amount corresponds to 47.94% of recent sales revenue.
Additionally, through a separate disclosure, the company stated that it has signed an identical supply contract worth 3.3 billion KRW in Greece.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
The company explained, "This contract is conditional upon obtaining regulatory approval in the respective sales regions, and if the conditions are not met, no sales revenue may be generated from the contract."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
